Adverum Biotechnologies, Inc. (ADVM)
4.36
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Adverum Biotechnologies Shareholders Equity (Quarterly) : -55.65M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -55.65M |
| June 30, 2025 | -20.22M |
| March 31, 2025 | 26.42M |
| December 31, 2024 | 70.71M |
| September 30, 2024 | 144.12M |
| June 30, 2024 | 168.03M |
| March 31, 2024 | 182.29M |
| December 31, 2023 | 67.22M |
| September 30, 2023 | 102.71M |
| June 30, 2023 | 131.16M |
| March 31, 2023 | 157.76M |
| December 31, 2022 | 181.52M |
| September 30, 2022 | 208.34M |
| June 30, 2022 | 244.12M |
| March 31, 2022 | 282.95M |
| December 31, 2021 | 316.18M |
| September 30, 2021 | 346.00M |
| June 30, 2021 | 379.14M |
| March 31, 2021 | 414.82M |
| December 31, 2020 | 434.35M |
| September 30, 2020 | 464.71M |
| June 30, 2020 | 282.56M |
| March 31, 2020 | 303.95M |
| December 31, 2019 | 174.96M |
| Date | Value |
|---|---|
| September 30, 2019 | 164.21M |
| June 30, 2019 | 177.74M |
| March 31, 2019 | 188.14M |
| December 31, 2018 | 201.17M |
| September 30, 2018 | 215.55M |
| June 30, 2018 | 233.45M |
| March 31, 2018 | 246.04M |
| December 31, 2017 | 184.03M |
| September 30, 2017 | 180.99M |
| June 30, 2017 | 192.18M |
| March 31, 2017 | 201.38M |
| December 31, 2016 | 215.60M |
| September 30, 2016 | 236.23M |
| June 30, 2016 | 247.65M |
| March 31, 2016 | 241.57M |
| December 31, 2015 | 252.59M |
| September 30, 2015 | 262.33M |
| June 30, 2015 | 270.63M |
| March 31, 2015 | 279.68M |
| December 31, 2014 | 149.48M |
| September 30, 2014 | 155.74M |
| June 30, 2014 | 43.04M |
| March 31, 2014 | -0.725M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 72.40M |
| Total Liabilities (Quarterly) | 128.05M |